Despite almost 100% of adolescents using intensive insulin therapy by 2016, rates of overweight and obesity were unchanged from 2004–2016 (39% vs. 29% in the 10–13 year group and 40% vs. 40% in the 14–17 year group). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.